iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Sees Large Decline in Short Interest

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 47,511 shares, a decrease of 61.4% from the April 15th total of 123,125 shares. Based on an average daily volume of 55,288 shares, the short-interest ratio is currently 0.9 days. Approximately 0.9% of the shares of the company are sold short.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

Hedge funds have recently modified their holdings of the business. Portland Global Advisors LLC increased its stake in shares of iShares Genomics Immunology and Healthcare ETF by 0.7% in the 3rd quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock worth $2,432,000 after purchasing an additional 684 shares in the last quarter. Ameriprise Financial Inc. raised its holdings in iShares Genomics Immunology and Healthcare ETF by 8.4% in the 3rd quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after purchasing an additional 5,540 shares during the period. Finally, Triumph Capital Management purchased a new position in iShares Genomics Immunology and Healthcare ETF during the third quarter valued at $35,000.

iShares Genomics Immunology and Healthcare ETF Price Performance

Shares of IDNA traded down $0.18 on Thursday, reaching $29.62. The company’s stock had a trading volume of 22,773 shares, compared to its average volume of 42,224. The stock’s 50 day simple moving average is $29.57 and its two-hundred day simple moving average is $28.20. The stock has a market capitalization of $161.43 million, a P/E ratio of 14.76 and a beta of 0.97. iShares Genomics Immunology and Healthcare ETF has a 12-month low of $19.19 and a 12-month high of $31.41.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.